Whole-brain radiotherapy can be delivered more safely to patients with brain metastases by avoiding the hippocampus according to a randomized phase III NRG Oncology trial presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
All news from Radiology/ Radiotherapy
Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel Cancer Center—Jefferson Health and Lankenau Institute for Medical Research scientists find that a gene involved in the immune system called IDO2 plays a significant role in pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer.
The long-term follow up of the NRG Oncology trial RTOG 9408, studying the addition of short-term androgen-deprivation therapy (ADT) to radiotherapy (RT) for men with early, localized prostate adenocarcinoma, indicated that RT combined with ADT is superior to RT alone for overall survival (OS) up to 10.4 years following treatment.
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
RaySearch Laboratories AB (publ), a medical technology company, and Canon Medical Systems Corporation (Canon Medical) have entered into a collaboration agreement to facilitate a close integration between RaySearch’s advanced software products RayStation and RayCare, and Canon Medical’s imaging systems and advanced visualization solutions.
Elekta employees joined national and local political representatives and distinguished guests this week in a ribbon cutting ceremony to mark the official opening of the company's Cornerstone campus.
A new device that combines low-intensity laser light and therapeutic ultrasound considerably reduces the pain experienced by patients with fibromyalgia. Fibromyalgia is a chronic disease that involves widespread nonarticular high-intensity pain lasting longer than three months.
For older patients with stage I squamous cell carcinoma of the anus, radiation alone is associated with outcomes that do not differ significantly from those of chemoradiation, according to research published in the July issue of Diseases of the Colon & Rectum.